MARIE KRESSE: Open Payments
NPI 1841298858 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,605 in 151 payments from 22 companies in 2025. Trend: 2023 $2,836 · 2024 $2,563 · 2025 $2,605
Food & beverage: $2,605
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $500 |
| ABBVIE INC. | 20 | $285 |
| E.R. Squibb & Sons, L.L.C. | 18 | $233 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $210 |
| Galderma Laboratories, L.P. | 14 | $173 |
| Novartis Pharmaceuticals Corporation | 13 | $168 |
| Lilly USA, LLC | 7 | $158 |
| Amgen Inc. | 9 | $157 |
| Organon LLC | 6 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
Products named: Bimzelx, Sotyktu, SKYRIZI, ILUMYA, NEMLUVIO, OTEZLA, TALTZ, COSENTYX.
Industry payments across IA — which companies pay providers there.
